The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system
Abstract
Objective: To identify the mediator responsible for the impact of chronic inflammation on skeletal development in children (bone loss, defective peak bone mass accrual, stunted growth), we evaluated the effects of chronic interleukin‐6 (IL‐6) overexpression on the skeletons of growing prepubertal mice. Methods: We studied IL‐6–transgenic mice that had high circulating IL‐6 levels since birth. Trabecular and cortical bone structure were analyzed by microcomputed tomography. Epiphyseal ossification, growth plates, and calvariae were studied by histology/histomorphometry. Osteoclastogenesis, osteoblast function/differentiation, and the effects of IL‐6 on bone cells were studied in vitro. Osteoblast gene expression was evaluated by reverse transcriptase–polymerase chain reaction. The mineral apposition rate was evaluated dynamically in cortical bone by in vivo double fluorescence labeling. Results: In prepubertal IL‐6–transgenic mice, we observed osteopenia, with severe alterations in cortical and trabecular bone microarchitecture, as well as uncoupling of bone formation from resorption, with decreased osteoblast and increased osteoclast number and activity. Increased osteoclastogenesis and reduced osteoblast activity, secondary to decreased precursor proliferation and osteoblast function, were present. IL‐6–transgenic mice also showed impaired development of growth plates and epiphyseal ossification centers. Intramembranous and endochondral ossification and the mineral apposition rate were markedly affected, showing the presence of defective ossification. Conclusion: Chronic overexpression of IL‐6 alone induces a skeletal phenotype closely resembling growth and skeletal abnormalities observed in children with chronic inflammatory diseases, pointing to IL‐6 as a pivotal mediator of the impact of chronic inflammation on postnatal skeletal development. We hypothesize that IL‐6–modifying drugs may reduce skeletal defects and prevent the growth retardation associated with these diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 transgenic mice exhibit osteopenia with increased osteoclast and decreased osteoblast populations (De Benedetti et al., 2006”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as De Benedetti et al., 2006
Citations
Cites
De Benedetti, F., Alonzi, T., Moretta, A., Lazzaro, D., Costa, P., Poli, V, Martini, A., Ciliberto, G., & Fattori, E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119207 · Cited by 529
Inhibition of IL-6 for the treatment of inflammatory diseases
NISHIMOTO, N. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.005 · Cited by 200
The anabolic effects of GH/IGF system on bone
Kasukawa, Y., Miyakoshi, N., & Mohan, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383764 · Cited by 65
Research works printed but not linked: 44
- 10.1016/S0889-857X(05)70345-8 · DOI
- 10.1007/s11926-004-0086-0 · DOI
- 10.1136/ard.15.4.295 · DOI
- 10.1093/rheumatology/kei091 · DOI
- 10.1002/art.1780401108 · DOI
- 10.1002/art.20963 · DOI
- 10.1002/art.20946 · DOI
- 10.1007/s10254-003-0012-2 · DOI · Paper page
- 10.1073/pnas.90.24.11924 · DOI
- 10.1016/j.bone.2005.06.002 · DOI
- 10.1002/j.1460-2075.1994.tb06368.x · DOI
- 10.1002/jbmr.5650020617 · DOI
- 10.1172/JCI200523394 · DOI
- De Benedetti F, 2001, Effect of IL‐6 on IGF binding protein‐3: a study in IL‐6 transgenic mice and in patients with systemic juvenile idiopathic arthritis, Endocrinology, 142, 4818, 10.1210/endo.142.11.8511 · DOI
- 10.1111/j.1460-9568.1995.tb01042.x · DOI
- 10.4049/jimmunol.166.7.4334 · DOI
- 10.1172/JCI117206 · DOI
- 10.1016/S8756-3282(02)00915-8 · DOI
- 10.1080/03008200390152232 · DOI
- 10.1007/s007740170044 · DOI
- Kitamura H, 1995, Bone marrow neutrophilia and suppressed bone turnover in human interleukin‐6 transgenic mice: a cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow, Am J Pathol, 147, 1682
- 10.1172/JCI19872 · DOI
- Raisz LG, 1999, Physiology and pathophysiology of bone remodeling, Clin Chem, 45, 1353
- 10.1136/adc.2004.053553 · DOI
- 10.1097/01.blo.0000156001.78631.e9 · DOI
- 10.1074/jbc.M110773200 · DOI
- 10.1006/cbir.1995.1088 · DOI
- 10.1530/eje.1.01874 · DOI
- 10.1084/jem.187.4.461 · DOI · Paper page
- 10.1006/cyto.1999.0502 · DOI
- 10.1016/S0002-9440(10)64846-8 · DOI
- 10.1172/JCI200421795 · DOI
- 10.1002/art.21537 · DOI
- 10.1159/000064759 · DOI
- 10.1097/00042737-200308000-00004 · DOI
- 10.1053/prrv.2001.0167 · DOI
- 10.1136/thx.2003.012047 · DOI
- 10.1542/peds.2004-0417 · DOI
- 10.1016/S0022-3476(64)80151-7 · DOI
- 10.1164/ajrccm.162.5.2002100 · DOI
- 10.1359/jbmr.2002.17.4.695 · DOI
- 10.1002/art.20944 · DOI
- 10.1053/j.gastro.2004.01.012 · DOI · Paper page
- 10.1002/art.20303 · DOI
Cited by
Sorted by citations
Muscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
“Overexpression of IL-6 in IL-6 transgenic mice resulted in increased osteoclastogenesis (163).”
BackgroundTargeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
Axmann, R., Böhm, C., Krönke, G., Zwerina, J., Smolen, J., & Schett, G. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24781 · Cited by 263
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Kishimoto, T., & Kang, S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-023458 · Cited by 140
Metadata
- Authors
- De Benedetti, F., Rucci, N., Del Fattore, A., Peruzzi, B., Paro, R., Longo, M., Vivarelli, M., Muratori, F., Berni, S., Ballanti, P., Ferrari, S., & Teti, A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-10-30
- Volume
- 54
- Issue
- 11
- Pages
- 3551-3563
- ISSN
- 0004-3591
- 1529-0131
- Cited by
- 296
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. https://app.cochat.ai/papers/10.1002/art.22175
- The paper
- De Benedetti, F., Rucci, N., Del Fattore, A., Peruzzi, B., Paro, R., Longo, M., Vivarelli, M., Muratori, F., Berni, S., Ballanti, P., Ferrari, S., & Teti, A. (2006). Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis & Rheumatism. https://doi.org/10.1002/art.22175